![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 25, 19060-19067, June 23, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Microbiology, University of Guelph,
Guelph, Ontario N1G 2W1 and the ¶ Institute for Biological
Sciences, National Research Council,
Ottawa, Ontario K1A 0R6, Canada
Received for publication, February 10, 2000, and in revised form, March 13, 2000
B-band lipopolysaccharide is an important
virulence factor of the opportunistic pathogen Pseudomonas
aeruginosa. WbpP is an enzyme essential for B-band
lipopolysaccharide production in serotype O6. Sequence analysis
suggests that it is involved in the formation of
N-acetylgalacturonic acid. To test this hypothesis,
overexpression and biochemical characterization of WbpP were performed.
By using spectrophotometric assays and capillary electrophoresis, we
show that WbpP is a UDP-GlcNAc C4 epimerase. The Km
for UDP-GlcNAc and UDP-GalNAc are 197 and 224 µM,
respectively. At equilibrium, 70% of UDP-GalNAc is converted to
UDP-GlcNAc, whereas the yield of the reverse reaction is only 30%. The
enzyme can also catalyze the inter-conversion of non-acetylated
substrates, although the efficiency of catalysis is significantly
lower. Only 15 and 40% of UDP-Glc and UDP-Gal, respectively, are
converted at equilibrium. WbpP contains tightly bound NAD(H) and does
not require additional cofactors for activity. It exists as a dimer in
its native state. This paper is the first report of expression and
characterization of a C4 UDP-GlcNAc epimerase at the biochemical level.
Moreover, the characterization of the enzymatic function of WbpP will
help clarify ambiguous surface carbohydrate biosynthetic pathways in P. aeruginosa and other organisms where homologues of WbpP exist.
Pseudomonas aeruginosa is an opportunistic
Gram-negative bacterium that can cause life-threatening infections in
patients with cystic fibrosis or burn wounds (1). It produces a wide variety of virulence factors such as proteases, toxins, alginate, and
lipopolysaccharides (LPS).1
Two forms of LPS have been identified as follows: the antigenically conserved A-band LPS, and the variable O-antigen or B-band. B-band LPS
is particularly important in the initial steps of the infection and
particularly for evasion of host defenses and colonization (2, 3). It
contributes to causing initial tissue damage and inflammatory responses
in the lungs of patients with cystic fibrosis (2). P. aeruginosa mutants deficient in B-band LPS biosynthesis are more
sensitive to serum killing (1, 4, 5) and are more susceptible to
phagocytosis (6) than wild-type bacteria. They are found almost
avirulent in mouse models (2). B-band LPS is the basis for
classification of P. aeruginosa in 20 different serotypes.
Among these, serotypes O6 and O11 are the most clinically
relevant in epidemiological studies (7). To date, the prognosis for a
cystic fibrosis patient infected with either serotype of P. aeruginosa is rather poor due to intrinsic multidrug
resistance of P. aeruginosa. Such resistance is due partly to a highly impermeable outer membrane and partly to the presence of multidrug efflux pumps (8-10). Hence, B-band LPS
biosynthesis has become an important target for drug discovery.
The genetics of B-band LPS biosynthesis are well documented in
serotypes O5, O6, and O11 (11-13) and were thoroughly reviewed recently (14). For each of these serotypes, the entire cluster of genes
responsible for B-band LPS synthesis has been sequenced, and putative
pathways for the synthesis of the corresponding O-antigens have been
proposed based on homology studies. In serotype O11, the functional
role of these genes awaits further studies. However, in serotypes O5
and O6, extensive functional characterization has been performed by
knockout construction and complementation analysis, using not only
genes from P. aeruginosa but also homologues found in other
organisms. Despite these efforts, ambiguities persist that can only be
alleviated by direct biochemical characterization of the proteins
involved. Such a characterization will also allow screening for
inhibitors that might be useful for therapeutic purposes, especially if
performed for enzymes found in the clinically relevant serotype O6.
The O-antigen of B-band LPS of serotype O6 consists of a
tetrasaccharide repeat of A functional assignment relying mainly on homology studies is
particularly problematic in the case of putative epimerases. Epimerases
belong to the short chain
dehydrogenase/reductase (SDR) enzyme family. This
family includes enzymes responsible for a wide variety of functions
(20-22). Most of these enzymes possess common features that include
the presence of the GXXGXXG signature for
nucleotide-binding proteins and the presence of alternating Materials--
Unless stated otherwise all chemical reagents
used were from Sigma. Restriction enzymes and T4 DNA ligase were from
Life Technologies, Inc. Pwo DNA polymerase was from Roche Molecular
Biochemicals. The dNTPs were from Perkin-Elmer. The His6
anti-histidine tag antibody was from Qiagen (Santa Clarita, CA). Agar
was from Difco. All kits or enzymes were used following the
manufacturer's instructions.
Cloning and Overexpression of WbpP in the pET System--
WbpP
was cloned in the NcoI and EcoRI sites of a pET23
derivative (26) with an N-terminal histidine tag. The sequence of the
primers used to amplify wbpP by polymerase chain reaction from genomic DNA (strain IATS O6) were
5'CAATGCCATGGGAATGATGAGTCGTTATGAAG3' and
5'TTAACGAATTCTCATTTCAAAAACATGATG3' for the top and bottom primers, respectively. The polymerase chain reaction consisted of 100 ng of genomic DNA, 0.5 µM each primer, 0.2 mM
each dNTP, 4 mM MgCl2, and 1× buffer in a
total of 50 µl. A 5-min denaturation at 94 °C was done before
addition of DNA polymerase (1.5 units of Pwo). This was followed by 15 cycles of 1 min at 94 °C, 45 s at 55 °C, and 90 s at
72 °C. A final 7-min elongation was performed at 72 °C. The
constructs obtained were checked by restriction analysis and sequencing.
The construct was subsequently transformed into the expression strain
BL21(DE3)pLysS (Novagen, Madison, WI) with ampicillin (100 µg/ml) and
chloramphenicol (35 µg/ml) selection. For protein expression, 2 ml of
an overnight culture were inoculated into 100 ml of LB in the presence
of ampicillin and chloramphenicol. The culture was grown at 30 °C.
When the A600 nm reached 0.6, IPTG (Promega,
Madison, WI) was added to a final concentration of 0.15 mM
and expression was allowed to proceed for 5-6 h at 30 °C.
Cells were harvested by centrifugation at 5,000 × g
for 15 min at 4 °C and the pellet was stored at Purification of WbpP by Chromatography--
Cells sedimented
from 100 ml of induced culture were resuspended in 10 ml of buffer A (5 mM imidazole, 20 mM Tris, pH 8, 0.1 M NaCl). The cells were briefly sonicated (macrotip,
sonicator XL2020 Heat Systems Inc., power set to 4, 2 min total, 5 s on, 5 s off) on ice. Cell debris was removed by centrifugation
at 13,000 × g for 15 min at 4 °C, and the
supernatant was applied to a 3-ml fast flow chelating Sepharose column
(Amersham Pharmacia Biotech) previously loaded with nickel sulfate (30 ml of 0.1 M) and equilibrated with 5 column volumes (CV) of
buffer A. Loading of the sample as well as all washing and elution
steps were done by gravity. After loading of the sample, the column was
washed with 10 CV of buffer A and 5 CV of buffer B (20 mM
imidazole, 20 mM Tris, pH 8, 0.1 M NaCl).
Elution was carried out with 3 CV of buffer C (1 M
imidazole, 20 mM Tris, pH 8, 0.1 M NaCl). Fractions were collected every 1 CV. Most of the protein was eluted in
fraction 2 as seen by SDS-PAGE analysis. This fraction was subjected to
further purification by anion exchange chromatography after dilution
1/30 in 50 mM Tris, pH 8. Half of it was loaded onto a 1-ml
column of Q-Sepharose fast flow (Amersham Pharmacia Biotech). The
column was washed with 30 CV of Tris buffer, and the protein was eluted
with 3 CV of 50 mM Tris, pH 8, 0.5 M NaCl. Fractions were collected every 1 CV, and most of the protein was recovered in fraction 2. This fraction was desalted by overnight dialysis (cut-off 3500 Da) in 50 mM Tris, pH 8, at 4 °C.
The dialyzed samples were concentrated by overlay with PEG 8000 (Sigma)
for 2-3 h at 4 °C. Protein quantitation was done using the BCA
reagent (Pierce). The purified enzyme was either used fresh or stored at Determination of the Oligomerization Status by Gel Filtration
Analysis--
A 45 × 1.6-cm column containing 90 ml of Sephadex
G-100 (Sigma, fractionation range 4-150 kDa) was used to determine the
oligomerization status of WbpP. The column was equilibrated in 50 mM Tris, pH 8, containing 100 mM NaCl and run
at 1.4 ml/min. Molecular weight standards (Sigma, 12-150 kDa) were
applied onto the column one by one (50-200 µg each in 200 µl).
WbpP was applied onto the column either as a concentrated or a diluted
solution (200 µg or 50 µg/200 µl deposited). Protein elution was
monitored at 280 nm.
Extraction of NAD(H) from Purified WbpP--
A freshly purified
and extensively dialyzed sample of WbpP at 1.75 mg/ml in 50 mM Tris, pH 8, was used for the extraction and
quantification of bound NAD(H). WbpP (175 µg) was incubated in the
presence of 10 µg of proteinase K for 45 min at 37 °C. Total
digestion of WbpP was checked by SDS-PAGE analysis and Coomassie staining. After complete digestion, WbpP was submitted to chemical reduction by successive additions of 1 µl of 10 mg/ml sodium
borohydride (Fisher) every 30 min for 2 h 30 min. The proteolysis
step was included prior to reduction to ensure quantitative reduction
and recovery of NAD(H). The absorption spectrum was recorded before and
after chemical reduction between 230 and 450 nm using a DU520 spectrophotometer (Beckman Instruments, Fullerton, CA) equipped with a
50-µl microcell. Serial dilutions of NAD+ (Sigma) ranging
from 5 to 40 µM were prepared in 50 mM Tris, pH 8, and were incubated at 37 °C for the same amount of time as
WbpP with or without chemical reduction. The precise concentration in
NAD+ was calculated using Determination of the Enzymatic Conversion of UDP-GlcNAc and
UDP-GalNAc Using p-Dimethylaminobenzaldehyde (DMAB)--
Reactions
were performed with a total reaction volume of 35 µl at 37 °C in
20 mM Tris, pH 8, unless stated otherwise. The specific
amount of enzyme used, substrate concentrations, and incubation time
are indicated in the legend of each figure. The reactions were stopped
by acid hydrolysis of the UDP moiety of the substrate. For this
purpose, the samples were acidified to pH 2 by addition of 7 µl of
HCl 0.1 N, boiled for 6 min, and neutralized by addition of
7 µl of NaOH 0.1 N. For the spectrophotometric quantification of GalNAc and GlcNAc, the reagent DMAB was prepared at
10% in glacial acetic acid/HCl, 9/1, v/v, and further diluted 1/10 in
glacial acetic acid before use (27). For the assay itself, 100 µl of
0.2 M sodium tetraborate, pH 9.1, were added to 50 µl of
quenched and neutralized enzymatic reactions and boiled immediately for
3 min. 40 µl of this mixture were transferred to a microtitration plate, and 200 µl of DMAB reagent were added. After incubation for 30 min at 37 °C, the A595 nm was recorded using
a microplate reader. The assay was done in duplicate for each reaction
tested. Standard curves were prepared using UDP-GlcNAc and UDP-GalNAc that were subjected to acid hydrolysis in the same conditions as
described above.
Determination of the Kinetic Parameters for UDP-GlcNAc and
UDP-GalNAc by Capillary Electrophoresis--
Reactions were performed
at 37 °C in 20 mM Tris, pH 8, with a total reaction
volume of 44 µl. The amount of purified enzyme added was 234 and 117 ng for reaction with UDP-GlcNAc and UDP-GalNAc, respectively. After
incubation at 37 °C for the required amount of time, the reactions
were quenched by boiling the sample for 6 min. Time course studies were
performed with final sugar nucleotide concentrations of 0.075 and 1.75 mM. Samples were quenched after 0, 2, 4, 6, 8, 10, and 15 min. For Km and Vmax
determinations, the final sugar nucleotide concentrations ranged from
0.075 to 1.75 mM, and the reactions were quenched after 3 min of incubation.
Capillary electrophoresis (CE) analysis was performed using a P/ACE
5000 system (Beckman Instruments, Fullerton, CA) with UV detection. The
running buffer was 25 mM sodium tetraborate, pH 9.4. The
capillary was bare silica 75 µm × 57 cm, with a detector at 50 cm. The capillary was conditioned before each run by washing with 0.2 M NaOH for 2 min, water for 2 min, and running buffer for 2 min. Samples were introduced by pressure injection for 4 s, and
the separation was performed at 22 kV. Peak integration was done using
the Beckman P/ACE Station software. The calculation of kinetic
parameters was done using the PRISM program.
Study of the Requirement for NAD+ or Divalent Cations
for Enzymatic Activity--
To assess the requirements for
NAD+ or divalent cations for the enzymatic activity of
WbpP, reactions were carried out with or without NAD+ (1 mM final concentration) and with or without divalent
cations (4 mM final concentration of MnCl2,
MgCl2, or CaCl2) and monitored by capillary
electrophoresis as described above.
Spectrophotometric Study of the Epimerization of UDP-Glc and
UDP-Gal by WbpP--
The enzymatic reactions were performed in 20 mM Tris, pH 8, with 39 µg of freshly purified enzyme and
0.8 mM sugar nucleotide in a total reaction volume of 44 µl. Time course studies were performed over 2 h at 37 °C.
After incubation for the required amount of time, the reactions were
quenched by acid hydrolysis of the UDP moiety as described above.
Standard curves were prepared using UDP-Glc or UDP-Gal that were also
subjected to acid hydrolysis. The quantitation of remaining glucose
present in the reaction mixture was measured spectrophotometrically
using a coupled assay adapted from Moreno et al. (28). A
reaction mix containing 22 units/ml glucose oxidase, 7 units/ml
horseradish peroxidase, and 0.3 mg/ml of O-dianisidine was
prepared in 50 mM sodium acetate buffer, pH 5.5. Four
hundred µl of this reaction mix were added to the neutralized samples
described above, and the reaction was allowed to proceed for 30 min at
37 °C. The reaction was then quenched by addition of 600 µl of 6 N HCl, and the absorbance at 540 nm was read.
Determination of the Kinetic Parameters for UDP-Glc and UDP-Gal
by Capillary Electrophoresis--
The enzymatic reactions were
performed in 20 mM Tris, pH 8, with 16.4 µg of freshly
purified enzyme in a total reaction volume of 44.8 µl. The total
sugar nucleotide concentrations in the enzymatic reactions ranged from
0.048 to 2.009 mM. The reactions were quenched after 15 min
of incubation at 37 °C. The samples were analyzed by CE in the same
conditions as described above, and the Km and
Vmax values were determined using the PRISM software.
Protein Expression and Purification--
WbpP is a 37.7-kDa
protein with a slightly acidic isoelectric point (pI = 5.99). It
was expressed in the pET system as an N-terminally histidine-tagged
protein. Provided that expression was carried out at low temperature
(30 °C) and with a low concentration of inducer IPTG (0.15 mM), most of the protein was expressed in a soluble form
(Fig. 2). It was expressed at a very high
level since it represented 30-35% of total cellular proteins. It was readily purified to 90-95% by nickel chelation, and most of the contaminants were further eliminated by anion exchange chromatography to produce 95-98% pure protein. Therefore, the protein was purified only 3-fold to reach homogeneity. The yield obtained was 5-7 mg/100 ml
of culture (Table I). The presence of the
histidine tag was confirmed by Western immunoblot using an
anti-histidine tag antibody (data not shown).
Results from gel filtration analysis suggest that WbpP exists as a
dimer in its native form (data not shown). No apparent monomer or
higher order oligomers were detected even in the presence of 100 mM salt or at low enzyme concentration.
Characteristics of the Spectrophotometric Assay Used for the
Quantitation of GlcNAc and GalNAc--
The spectrophotometric assay
used to quantitate GlcNAc and GalNAc in enzymatic reactions relies on
the use of DMAB which is specific for N-acetylhexosamines.
Different colorimetric yields are obtained with different
N-acetylhexosamines (27). For the two substrates relevant to
this study, a much higher reaction yield (6 times) is obtained with
GlcNAc than with GalNAc (Fig. 3A). The assay is very
sensitive and allows discrimination between both substrates at low
substrate concentration (0.15 mM). Moreover, the yields of
reaction are additive. Hence, the composition of a mixture of GlcNAc
and GalNAc obtained after enzymatic conversion can be calculated from
standard curves established with each substrate separately (Fig.
3B).
Functional Characterization of WbpP Using the DMAB Assay--
The
results obtained for WbpP using the DMAB assay are consistent with a
UDP-GlcNAc C4 epimerase activity. When the enzymatic reaction was
performed with UDP-GlcNAc, the total yield of the reaction with DMAB
decreased (Fig. 3C). This is consistent with the formation
of GalNAc that reacts poorly with DMAB. Alternatively, when the
enzymatic reaction was performed with UDP-GalNAc, the yield of the
reaction with DMAB increased. This is consistent with the formation
GlcNAc that reacts strongly with DMAB. The activity was dependent on
the quantity of enzyme added (Fig. 3C). Maximum substrate
conversions obtained were approximately 30% for UDP-GlcNAc and 70% of
UDP-GalNAc. Less enzyme was required to obtain maximum substrate
conversion for UDP-GalNAc than for UDP-GlcNAc. The specific activity of
purified WbpP was 5.6 and 2.3 units/mg with regard to UDP-GalNAc and
UDP-GlcNAc, respectively (Table I). This represents only a 2-fold
increase of the specific activity. This apparent low level of
purification in terms of specific activity is due to the fact that the
protein was expressed at a very high level.
Characterization of the C4 UDP-GlcNAc Epimerase Activity by
Capillary Electrophoresis Analysis--
Capillary electrophoresis was
used to confirm the identity of the reaction products after enzymatic
conversion of UDP-GlcNAc or UDP-GalNAc by WbpP by comparison with
standard compounds. Under analytical conditions, UDP-GlcNAc and
UDP-GalNAc are well resolved, with peaks at 11.6 and 12.3 min,
respectively. Fig. 4 shows that UDP-GlcNAc and UDP-GalNAc are inter-converted into one another by WbpP,
thus confirming its C4 epimerase activity on these substrates. At
equilibrium, the yields of enzymatic conversion are the same as
calculated from the DMAB assay data.
Determination of the Kinetic Parameters for UDP-GlcNAc and
UDP-GalNAc by Capillary Electrophoresis--
Time course experiments
performed with different enzyme dilutions indicate that the rate of
conversion of UDP-GlcNAc is much slower than that of UDP-GalNAc at
equal enzyme dilution (Fig. 5). Initial
rate conditions were selected by choosing the enzyme dilutions that
allow transformation of less than 10% of the substrate in 3 min, for
substrates concentrations ranging from 0.02 to 1.75 mM. The
Km and Vmax parameters of
WbpP for each substrate were determined under these initial rates
conditions (Table II). The
Km values derived from Eadie-Hofstee plots are 224 and 197 µM for UDP-GlcNAc and UDP-GalNAc, respectively.
The enzyme shows an equal affinity for these substrates.
Determination of the Physicochemical Parameters: Optimal pH,
Temperature, and Storage Conditions--
WbpP has a broad pH range of
activity, with significant activity observed for pH > 6.5 and an
optimum between pH 7 and 8 (data not shown). The enzyme is also active
over a wide range of temperatures (data not shown) with an optimum
between 37 and 42 °C. The enzyme can be kept active without any
significant loss of activity when stored at Substrate Specificity--
A glucose-specific spectrophotometric
assay (28) was used to study the substrate specificity for WbpP. By
using this assay, it was shown that WbpP can use UDP-Glc as a substrate
(Fig. 6), but the identity of the
reaction product is unknown. Also, UDP-Glc was produced when the
reaction was performed with UDP-Gal as a substrate. These results are
consistent with a C4 epimerase activity on the non-acetylated
substrates UDP-Glc and UDP-Gal. From these results, the product of
UDP-Glc modification by WbpP is expected to be UDP-Gal, but its
identity needs to be confirmed by analytical methods. Also, the rate of
conversion was significantly higher for UDP-Gal than UDP-Glc at equal
enzyme dilutions (Fig. 6). At equilibrium, approximately 40% of
UDP-Gal was transformed to UDP-Glc, whereas only 15% of UDP-Glc was
modified by the enzyme. Capillary electrophoresis analysis confirmed
without ambiguity that WbpP has C4 epimerase activity on UDP-Glc and
UDP-Gal (Fig. 7) and confirmed that the
maximum conversions were 40 and 17% for UDP-Gal and UDP-Glc,
respectively.
Determination of the Kinetic Parameters for UDP-Glc and
UDP-Gal by Capillary Electrophoresis--
The kinetic parameters
determined under initial rates conditions are summarized in Table II.
The Km values are 237 and 251 µM for
UDP-Glc and UDP-Gal, respectively. The Vmax
values are 54 and 82 pmol/min.
Analysis of NAD+ or Divalent Cation Requirements by
Capillary Electrophoresis--
The addition of NAD+,
Mg2+, Ca2+, or Mn2+ to the reaction
mixture was not necessary for the C4 epimerase activity of WbpP, would it be on the acetylated or non-acetylated forms of the substrates as
determined by capillary electrophoresis (data not shown).
Extraction of NAD+/NADH from Purified
WbpP--
Tightly bound NAD+/NADH could be extracted from
highly purified and extensively dialyzed WbpP after complete digestion
with proteinase K. The released nucleotide was reduced to NADH by
sodium borohydride treatment. A yield of 0.7-0.8 mol of NAD(H)/mol of WbpP was calculated from the absorbance at 340 nm (data not shown). This indicates that WbpP binds to the nucleotide tightly during its synthesis.
UDP-GlcNAc is an essential precursor of surface carbohydrate
biosynthesis (29), both in bacteria, where it is the precursor of
peptidoglycan, capsule, or lipopolysaccharide biosynthesis, and in
humans, where it is the main precursor involved in cell surface
sialylation (30). Although the requirements of UDP-GlcNAc-modifying enzymes such as C2 and C4 epimerases or C6 dehydratases (12, 13,
30-32) have been inferred from in vivo experiments and
structural analysis of various surface carbohydrates, very little
information is available at the biochemical level on the enzymes
responsible for such activities.
WbpP is a small protein essential for the biosynthesis of B-band LPS in
P. aeruginosa serotype O6 (12). Prior to this study, the
exact function of this enzyme was unknown. Sequence analysis showed
that it belongs to the short chain
dehydrogenase/reductase (SDR) family. The variety
of enzymatic functions represented in the SDR family doesn't allow for
a specific functional assignment for WbpP. Most enzymes belonging to
this family share the same initial steps of catalysis resulting in the
formation of a 4-hexosulose intermediate that can subsequently lead to
the formation of a variety of new carbohydrates such as epimers, deoxy
sugars, or branched carbohydrates. Therefore, belonging to this family
is not a sufficient criteria for specific functional assignment. Comparisons of the LPS composition of organisms that exhibit WbpP or a
homologue suggested that WbpP might be a C4 epimerase specific for
UDP-GlcNAc. The validity of such an assignment is supported by
successful complementation of a wbpP null mutant of P. aeruginosa by an S. typhimurium homologue,
wcdB. This homologue of wbpP has been shown to be
involved in the biosynthesis of a homopolymer of As mentioned previously, the existence of
UDP-N-acetylglucosamine 4-epimerase activity has been
inferred from the analysis of the surface carbohydrates of a variety of
organisms or even mammalian tissues. However, the experimental
demonstration of the existence of the activity has only been reported
on two occasions. The first one was the description of both UDP-GlcNAc
and UDP-Glc C4 epimerase activity associated with a protein fraction
isolated from porcine submaxillary gland (33). In this study, the
purified enzyme performs with equal or higher efficiency on the
non-acetylated substrates than on the acetylated ones. Hence, it is
doubtful that the activity arises from a genuine UDP-GlcNAc C4
epimerase but rather is a side reaction of a standard GalE homologue.
The sequence of the enzyme was not provided to resolve the question. In
the second case, a UDP-N-acetylglucosamine 4-epimerase
activity was linked with the gneA locus in Bacillus
subtilis (34). Assays were performed using whole cell extracts,
and the enzyme was not purified. Considering that the substrate and
product involved in this reaction are shared by a variety of sugar
nucleotide-modifying enzymes, results obtained using whole cell
extracts are not unequivocal. The biochemical characterization
described in this study and performed in vitro using
overexpressed and purified enzyme is the first unambiguous
demonstration of the existence of a specific UDP-GlcNAc C4 epimerase
and provides the first kinetic analysis of such an enzyme.
Although numerous spectrophotometric assays are available to study the
UDP-Glc C4 epimerase activity, none is available for the UDP-GlcNAc C4
epimerase activity. Most assays rely on the coupling of the
epimerization reaction to a secondary enzymatic reaction that is
usually very specific for the substrate or product in its
non-acetylated form (28, 35). A spectrophotometric assay using DMAB was
designed to measure C4 epimerase activity on the
N-acetylated substrates, UDP-GlcNAc and UDP-GalNAc. The results obtained with the DMAB assay as described in this study are
consistent with a C4 epimerase activity involving UDP-GlcNAc and
UDP-GalNAc. But other activities resulting in the production of
different N-acetylhexosamines derivatives with different
reactivities toward DMAB cannot be excluded. Hence, capillary
electrophoresis was used to provide the proof for the identity of the
reaction products. The results from CE analysis clearly confirmed that WbpP is a UDP-GlcNAc C4 epimerase.
The kinetic analysis was carried out under initial rate conditions
using the standard Michaelis-Menten model. One of the assumptions of
this model is that no product can be used as a substrate. The initial
rate conditions used in our study ensured that no more than 10% of the
substrate was used up by the enzyme, hence maintaining product
re-conversion to a minimum. The kinetic analysis revealed that WbpP has
the same affinity for UDP-GalNAc and UDP-GlcNAc, but the reaction
proceeds at a faster rate for the former than the latter. Moreover, the
kcat shows that for an equal amount of enzyme
present in the reaction, the conversion of UDP-GalNAc to UDP-GlcNAc is
more efficient than the reverse reaction. This is also apparent at
equilibrium where 70% of UDP-GalNAc are converted to UDP-GlcNAc,
whereas only 30% of UDP-GlcNAc are converted to UDP-GalNAc. Hence,
in vitro, the equilibrium is shifted toward the production
of UDP-GlcNAc. Such a shift of the equilibrium toward the production of
the glucose isomer has been previously reported for GalE from E. coli (35). However, this is opposite to what is expected in
vivo and in the pathway proposed for O-antigen biosynthesis in
serotype O6. The use of the product by the next enzyme involved in the
B-band LPS biosynthetic pathway pulls the equilibrium toward the
production of UDP-GalNAc in vivo. This could be part of a
regulatory mechanism. When the biosynthesis of LPS is down-regulated as
a function of varying environmental conditions (36), the UDP-GlcNAc
stock is not depleted by the activity of WbpP and stays available for
synthesis of other biologically important polymers such as
peptidoglycan. On the other hand, the low level of UDP-GlcNAc
conversion ensures that some precursors of LPS O-antigen are still
present in the cell. This allows for extremely fast LPS production
recovery as soon as normal environmental conditions are restored (36).
Finally, the kcat/Km ratio,
which is an indication of binding of the substrate to its site,
suggests that the differences obtained for both substrates are due to a
less efficient binding of UDP-GlcNAc in the substrate binding pocket
than of UDP-GalNAc.
The specificity of WbpP for the N-acetylated forms of the
substrates was investigated. This study was initiated with regard to
the current mechanism of action proposed for C4 epimerase GalE. The
epimerase binds tightly to its substrate via the UDP moiety, whereas
the sugar moiety is more loosely bound and rotates along the bond
between P As observed for the acetylated substrates, the equilibrium is also
shifted toward the production of UDP-Glc, but the maximum percentages
of substrate conversion are much lower than in the previous case. Only
40% of UDP-Gal are converted to UDP-Glc at equilibrium, and around
12% of UDP-Glc are converted to UDP-Gal. Although WbpP can epimerize
the non-acetylated substrates in vitro, the poor efficiency
of catalysis and high amounts of enzyme necessary to carry such
reactions indicate that these reactions are unlikely to happen in
vivo and that the acetylated forms of the substrates are the
preferred ones in vivo. Determination of the
three-dimensional structure and site-directed mutagenesis studies of
WbpP will help decipher the molecular basis for substrate specificity
in this enzyme. In P. aeruginosa, a genuine UDP-Glc C4
epimerase activity is required for the synthesis of the galactose
residue found in the LPS core. Since our data show that UDP-Glc is not
the preferred substrate for WbpP, this activity might be carried by a
yet uncharacterized homologue of WbpP. This is consistent with the fact
that inactivation of WbpP by gentamicin cassette insertion and allelic
replacement does not result in the production of a truncated core in
serotype O6 (12). This is also consistent with the observation that
Southern blotting experiments using the wbpP gene as a probe
reveal the existence of homologues in all 20 serotypes of P. aeruginosa that share common core structural motifs.
Overall, the Km values determined for WbpP and its
different substrates are within the range of values reported in the
literature for GalE epimerases from different sources (28, 33, 35, 41,
42). The wide variety of methods employed to assay activity and the
varying degrees of purity of enzyme preparations used in these studies
do not allow for more detailed comparisons of the kinetic parameters.
For both series of substrates, the enzyme is active without requiring
addition of exogenous NAD+ or divalent cations such as
Mg2+, Mn2+, or Ca2+. However, the
mechanism of C4 epimerization implies the participation of a
NAD+ molecule as an essential coenzyme (37). This molecule
is predicted to be bound in the Rossman fold delineated by the
alternating Most SDR enzymes exist as dimers or tetramers in their native state
(20). Our gel filtration data suggest that WbpP also forms a dimer.
However, in contrast to what has been previously described for a
UDP-GlcNAc C2 epimerase (47), no allosteric behavior was observed for WbpP.
In conclusion, this paper describes the first overexpression,
purification, and biochemical characterization of a C4 epimerase that
shows strong specificity for the N-acetylated substrates UDP-GlcNAc and UDP-GalNAc. Moreover, the unambiguous functional assignment of WbpP provides valuable information to help clarify surface carbohydrate biosynthetic pathways in a variety of organisms where no biochemical data were available.
We thank Dr. D. Mangroo (University of
Guelph) for providing the modified pET23 expression vector and M. J. Schur (National Research Council of Canada, Ottawa) for technical
assistance with CE analyses.
*
This work was supported in part by Grant MT14687 from the
Medical Research Council of Canada (to J. S. L.) and the Canadian Bacterial Diseases Network (a consortium of the Federal Networks of
Centres of Excellence).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Current address: College of Veterinary Medicine, Dept. of
Pathobiology, University of Florida, P. O. Box 110880, Gainesville, FL
32611-0880.
Published, JBC Papers in Press, March 15, 2000, DOI 10.1074/jbc.M001171200
The abbreviations used are:
LPS, lipopolysaccharide;
DMAB, p-dimethylaminobenzaldehyde;
SDR, short chain dehydrogenase/reductase;
CE, capillary electrophoresis;
PAGE, polyacrylamide gel electrophoresis. IPTG,
isopropyl-1-thio-
Expression, Purification, and Biochemical Characterization of
WbpP, a New UDP-GlcNAc C4 Epimerase from Pseudomonas
aeruginosa Serotype O6*
,
§,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-
-D-3 O-acetyl, 6 amino-GalNAcA-(1
4)-
-D-6-amino-2-deoxy-2-formamido-D-galacturonic acid-(1
3)-
-D-2-acetamido-2,6-dideoxy-D-glucose-(1
2)-
-L-Rha-(1
(15-17). GalNAcA is thought to be synthesized in vivo
via epimerization and dehydrogenation of UDP-GlcNAc, the main precursor
of surface-associated carbohydrate synthesis (12, 18, 19). The product
of the epimerization reaction, UDP-GalNAc, is an important intermediate for the synthesis of polysaccharide structures that contain GalNAcA or
a derivative, not only in P. aeruginosa but also in other
organisms. The gene wbpP is part of the B-band LPS cluster
in P. aeruginosa O6 (12). The amino acid sequence of WbpP
shows 23% identity with the C4 UDP-Glc epimerase GalE from
Escherichia coli. It also shows 66% identity with WcdB, an
enzyme thought to be involved in the formation of GalNAcA residues
present in the Vi polysaccharide of Salmonella typhi (19).
Disruption of the wbpP gene in a knockout mutant results in
loss of B-band LPS production in P. aeruginosa, and this
deficiency is fully alleviated after complementation by the
wcdB homologue (12). Although no biochemical evidence is
available for either WbpP or WcdB, sequence comparisons with other
proteins and carbohydrate composition analysis suggest that they are C4
epimerases that transform UDP-GlcNAc into UDP-GalNAc in
vivo.
and
structures that delineate a typical nucleotide-binding Rossman fold at
their N terminus (23, 24). Moreover, they share a conserved catalytic
triad S(X)24-Y(X)3K
probably involved in initiation of the catalytic process. All these
features are present in WbpP, and they match perfectly with those found
in the C4 UDP-Gal epimerase GalE found in E. coli (Fig.
1) but also those of other enzymes with
different functions such as RFFG, a dTDP-glucose-4,6-dehydratase
present in E. coli (25). Hence, biochemical analysis is
necessary to prove without ambiguity the function of WbpP. Also,
although C4 UDP-Glc epimerases have been extensively studied
previously, no epimerase has been described for the
N-acetylated form of the substrate, but the existence of
such activity has been suspected in a variety of organisms. The study
of WbpP from P. aeruginosa serotype O6 described in this
paper is the first report of the overexpression, purification, and
detailed enzymatic analysis of a C4 UDP-GlcNAc epimerase.

View larger version (41K):
[in a new window]
Fig. 1.
Comparison of the primary and secondary
structural features of three members of the short chain
dehydrogenase/reductase family. WbpP from P. aeruginosa
serotype O6, the C4 UDP-Glc epimerase GalE from E. coli, and
the dTDP-glucose-4,6-dehydratase RFFG from E. coli. +,
identical amino acids; *, homologous amino acids; green
letters,
-sheets; pink letters,
-helices. The
conserved catalytic triad is highlighted in blue. The
GXXGXXG signature for NAD(P)+-binding
proteins is highlighted in bold. Secondary structure
predictions were made using the Expasy molecular biology software,
expasy.hcuge.ch.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
20 °C until
needed. Expression was monitored by SDS-PAGE analysis, with
Coomassie blue staining or Western immunoblot using the penta-His
anti-histidine tag antibody as instructed by the manufacturer.
20 °C in 25% glycerol or 20% adonitol in 50 mM
Tris, pH 8, without any significant loss of activity.
260 nm = 17400 M
1 × cm
1 and the efficiency of
reduction was calculated using
340 nm = 6270 M
1 × cm
1.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (45K):
[in a new window]
Fig. 2.
SDS-PAGE analysis of WbpP along its
purification. 30-µl aliquots were withdrawn at each step of the
purification described under "Experimental Procedures" and loaded
on a 10% SDS-PAGE gel. The detection was performed with Coomassie Blue
staining. WbpP eluted from the anion exchange (AE) column
was loaded in two lanes in different amounts to show purity and size.
MW, molecular weight markers.
Purification table for WbpP established using the DMAB assay and either
UDP-GlcNAc or UDP-GalNAc as a substrate

View larger version (12K):
[in a new window]
Fig. 3.
Study of the epimerization of UDP-GlcNAc and
UDP-GalNAc by WbpP using the DMAB assay. A, standard
curves obtained with each compound separately. Open circles,
UDP-GlcNAc; open squares, UDP-GalNAc. B,
comparison of the experimental data (closed triangles)
obtained for mixtures of UDP-GalNAc and UDP-GlcNAc of different
proportions (constant total sugar nucleotide concentration of 0.75 mM) and the theoretical data (open triangles)
calculated from the standard curves from A. C,
activity of WbpP as a function of the amount of enzyme added. The
reactions were performed with 0.75 mM substrate in a total
volume of 35 µl for 8 min at 37 °C. Closed circles,
UDP-GlcNAc; closed squares, UDP-GalNAc.

View larger version (12K):
[in a new window]
Fig. 4.
Capillary electrophoresis analysis of the
epimerization of UDP-GlcNAc and UDP-GalNAc by WbpP at equilibrium.
The reactions were performed in a total volume of 35 µl with 1.5 mM substrate and 17 µg of enzyme. They were incubated at
37 °C for 2 h. 1, UDP-GalNAc alone; 2,
UDP-GlcNAc alone; 3, UDP-GalNAc + WbpP; 4,
UDP-GlcNAc + WbpP.

View larger version (19K):
[in a new window]
Fig. 5.
Time course of epimerization of UDP-GlcNAc
and UDP-GalNAc by WbpP as measured by capillary electrophoresis.
Reactions were performed at 37 °C in 20 mM Tris, pH 8, with a total reaction volume of 44 µl. The amount of purified enzyme
added was 234 and 117 ng for reaction with UDP-GlcNAc and UDP-GalNAc,
respectively. Closed circles, UDP-GlcNAc 0.075 mM; closed squares, UDP-GalNAc 0.075 mM; open circles, UDP-GlcNAc 1.75 mM; open squares, UDP-GalNAc 1.75 mM.
Kinetic parameters for WbpP and its four substrates as determined by
capillary electrophoresis
20 °C in 25% glycerol
or 20% adonitol in 20 mM Tris, pH 8 (data not shown).

View larger version (20K):
[in a new window]
Fig. 6.
Time course for the epimerization of UDP-Glc
and UDP-Gal by WbpP using the glucose oxidase-coupled assay. Two
measurements were made per time point on the same enzymatic reaction.
The reactions were made with 33 µg of enzyme and 0.45 mM
substrate in a total volume of 44 µl. Squares, UDP-Gal;
circles, UDP-Glc. The same differences between both
substrates were observed when reactions were done with different enzyme
quantities (data not shown).

View larger version (14K):
[in a new window]
Fig. 7.
Capillary electrophoresis analysis of the
epimerization of UDP-Glc and UDP-Gal by WbpP at equilibrium. The
reactions were performed in a total volume of 35 µl with 1.5 mM substrate and 17 µg of enzyme. They were incubated at
37 °C for 2 h. 1, UDP-Gal alone; 2,
UDP-Glc alone; 3, UDP-Gal + WbpP; 4, UDP-Glc + WbpP.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-1,4
2-deoxy-2-N-acetylgalactosamine uronic acid (19). However, another homologue, WbpK, showing 51% homology to WbpP, is localized in
the gene cluster for B-band LPS biosynthesis in P. aeruginosa serotype O5 (PAO1) where its function is at present
unknown. The O5 LPS contains FucNAc, which was previously proposed to
arise from epimerization of UDP-GlcNAc to UDP-GalNAc followed by
dehydration and reduction to UDP-FucNAc. Hence, a UDP-GlcNAc C4
epimerase activity was also expected to exist in serotype O5.
WbpKO5 was the best candidate for such an epimerase as
judged by its high level of homology to WbpPO6.
Complementation analysis using a WbpKO5 knockout showed
that WbpPO6 is not able to rescue LPS biosynthesis in PAO1
(this study, data not shown). This suggests that WbpPO6 and
WbpKO5 have a different function and/or substrate
specificity despite their high level of sequence conservation. Hence,
in addition to providing the first description of a UDP-GlcNAc C4
epimerase at the biochemical level, the characterization of WbpP will
also be useful to clarify ambiguous biosynthetic pathways for LPS
biosynthesis in organisms that possess homologues of WbpP.
of UDP and O of the pyranosyl ring (37) while
catalysis proceeds. As a result, GalE has been shown to be able to
accommodate slightly different substrates, with different substitutions
at positions C-2 and C-6 (37-39). It can also bind very different
compounds as long as the UDP structure is preserved (40). In the case
of WbpP, the enzyme can still perform the epimerization of both UDP-Gal
and UDP-Glc with Km values of the same order as
those for the acetylated substrates. However, the
kcat and Vmax values
clearly indicate that the catalysis is ~1000-fold less efficient with
these substrates than with the acetylated ones. Moreover, the
kcat/Km ratio indicates that
the binding is quite poor, especially for UDP-Glc. This is reflected by
the fact that the epimerization of the non-acetylated substrates
requires the presence of significantly higher amounts of enzyme than
the epimerization of the acetylated substrates.
-helix and
-sheet structures and the
GXXGXXG motif at the N terminus of the protein.
The binding site has been mapped by NMR (43) and crystallography
studies (24, 44, 45) in GalE from E. coli. In GalE, the
NAD+ molecule is a redox cofactor responsible for
reversibly and non-stereospecifically dehydrogenating carbon 4 in the
pyranosyl rings of UDP-Glc and UDP-Gal. This NAD+ molecule
does not dissociate from the enzyme either in the course of catalysis
or between catalytic cycles. However, an NAD+-independent
epimerase that carries its function via carbon-carbon bond cleavage
rather than by a simple deprotonation-reprotonation mechanism was
recently described (46). In the case of WbpP, NAD(H) could be extracted
from purified and extensively dialyzed enzyme after complete
proteolysis and chemical reduction. This indicates that NAD(H) is
present and tightly bound to the enzyme as it is expressed in E. coli. This molecule of NAD(H) might be recycled internally without
being released into the external medium as has been proposed for GalE.
Structure determination of WbpP will confirm the presence of a bound
NAD+ molecule in WbpP and allow the mapping of its binding site.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
Recipient of postdoctoral fellowships from the Canadian Cystic
Fibrosis Foundation.
To whom correspondence should be addressed. Tel.: 519-824-4120 (ext. 3823); Fax: 519-837-1802; E-mail: jlam@uoguelph.ca.
![]()
ABBREVIATIONS
-D-galactopyranoside;
CV, column
volumes.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Hancock, R. E.,
Mutharia, L. M.,
Chan, L.,
Darveau, R. P.,
Speert, D. P.,
and Pier, G. B.
(1983)
Infect. Immun.
42,
170-177
2.
Cryz, S. J., Jr.,
Pitt, T. L.,
Furer, E.,
and Germanier, R.
(1984)
Infect. Immun.
44,
508-513
3.
Pier, G. B.,
and Thomas, D. M.
(1982)
J. Infect. Dis.
148,
217-223
4.
Schiller, N. L.,
and Hatch, R. A.
(1983)
Diagn. Microbiol. Infect. Dis.
1,
145-157
5.
Goldberg, J. B.,
and Pier, G. B.
(1996)
Trends Microbiol.
4,
490-494
6.
Engles, W.,
Endert, J.,
Kamps, M. A. F.,
and VanBoven, C. P. A.
(1985)
Infect. Immun.
49,
182-189
7.
Pitt, T. L.
(1989)
Antibiot. Chemother. (Wash. D. C.)
42,
1-7
8.
Poole, K.,
Krebes, K.,
McNally, C.,
and Neshat, S.
(1993)
J. Bacteriol.
175,
7363-7372
9.
Poole, K.,
Gotoh, N.,
Tsujimoto, H.,
Zhao, Q.,
Wada, A.,
Yamasaki, T.,
Neshat, S.,
Yamagishi, J.,
Li, X. Z.,
and Nishino, T.
(1996)
Mol. Microbiol.
21,
713-724
10.
Srikumar, R.,
Tsang, E.,
and Poole, K.
(1999)
J. Antimicrob. Chemother.
44,
537-540
11.
Burrows, L. L.,
Charter, D. F.,
and Lam, J. S.
(1996)
Mol. Microbiol.
22,
481-495
12.
Bélanger, M.,
Burrows, L. L.,
and Lam, J. S.
(1999)
Microbiology
145,
3505-3521
13.
Dean, C. R.,
Franklund, C. V.,
Retief, J. D.,
Coyne, M. J., Jr.,
Hatano, K.,
Evans, D. J.,
Pier, G. B.,
and Goldberg, J. B.
(1999)
J. Bacteriol.
181,
4275-4284
14.
Rocchetta, H. L.,
Burrows, L. L.,
and Lam, J. S.
(1999)
Microbiol. Mol. Biol. Rev.
63,
523-553
15.
Knirel, Y. A.,
Vinogradov, E. V.,
Shashkov, A. S.,
Dmitriev, B. A.,
Kochetkov, N. K.,
Stanislavsky, E. S.,
and Mashilova, G. M.
(1985)
Eur. J. Biochem.
150,
541-550
16.
Knirel, Y. A.
(1990)
Crit. Rev. Microbiol.
17,
273-304
17.
Knirel, Y. A.,
and Kochetkov, N. K.
(1994)
Biokhimiya
59,
1784-1851
18.
Kochetkov, N. K.,
and Shibaev, V. N.
(1973)
Adv. Carbohydr. Chem. Biochem.
28,
307-399
19.
Virlogeux, I.,
Waxin, H.,
Ecobichon, C.,
and Popoff, M. Y.
(1995)
Microbiology
141,
3039-3047
20.
Jornvall, H.,
Persson, B.,
Krook, M.,
Atrian, S.,
Gonzalez-Duarte, R.,
Jeffery, J.,
and Ghosh, D.
(1995)
Biochemistry
34,
6003-6013
21.
Jornvall, H.
(1999)
Adv. Exp. Med. Biol.
463,
359-364
22.
Jornvall, H.,
Hoog, J. O.,
and Persson, B.
(1999)
FEBS Lett.
445,
261-264
23.
Rossmann, M. G.,
and Argos, P.
(1975)
J. Biol. Chem.
250,
7525-7532
24.
Bauer, A. J.,
Rayment, I.,
Frey, P. A.,
and Holden, H. M.
(1992)
Proteins
12,
372-381
25.
Marolda, C. L.,
and Valvano, M. A.
(1995)
J. Bacteriol.
177,
5539-5546
26.
Newton, D. T.,
and Mangroo, D.
(1999)
Biochem. J.
339,
63-69
27.
Reissig, J. L.,
Strominger, J. L.,
and Leloir, L. F.
(1955)
J. Biol. Chem.
217,
959-966
28.
Moreno, F.,
Rodicio, R.,
and Herrero, P.
(1981)
Cell. Mol. Biol.
27,
589-592
29.
Shibaev, V. N.
(1986)
Adv. Carbohydr. Chem. Biochem.
44,
277-339
30.
Keppler, O. T.,
Hinderlich, S.,
Langner, J.,
Schwartz-Albiez, R.,
Reutter, W.,
and Pawlita, M.
(1999)
Science
284,
1372-1376
31.
Kiser, K. B.,
Bhasin, N.,
Deng, L.,
and Lee, J. C.
(1999)
J. Bacteriol.
181,
4818-4824
32.
Plumbridge, J.,
and Vimr, E.
(1999)
J. Bacteriol.
181,
47-54
33.
Piller, F.,
Hanlon, M. H.,
and Hill, R. L.
(1983)
J. Biol. Chem.
258,
10774-10778
34.
Estrela, A. I.,
Pooley, H. M.,
de Lencastre, H.,
and Karamata, D.
(1991)
J. Gen. Microbiol.
137,
943-950
35.
Wilson, D. B.,
and Hogness, D. S.
(1969)
J. Biol. Chem.
244,
2132-2136
36.
Creuzenet, C., Smith, M., and Lam, J. S. (1999) Pseudomonas
99: Biotechnology and Pathogenesis Conference, September 1-5,
Maui, HI Abstr. 93
37.
Frey, P. A.
(1996)
FASEB J.
10,
461-470
38.
Flentke, G. R.,
and Frey, P. A.
(1990)
Biochemistry
29,
2430-2436
39.
Thoden, J. B.,
Hegeman, A. D.,
Wesenberg, G.,
Chapeau, M. C.,
Frey, P. A.,
and Holden, H. M.
(1997)
Biochemistry
36,
6294-6304
40.
Thoden, J. B.,
Frey, P. A.,
and Holden, H. M.
(1996)
Protein Sci.
5,
2149-2161
41.
Swanson, B. A.,
and Frey, P. A.
(1993)
Biochemistry
32,
13231-13236
42.
Quimby, B. B.,
Alano, A.,
Almashanu, S.,
DeSandro, A. M.,
Cowan, T. M.,
and Fridovich-Keil, J. L.
(1997)
Am. J. Hum. Genet.
61,
590-598
43.
Konopka, J. M.,
Halkides, C. J.,
Vanhooke, J. L.,
Gorenstein, D. G.,
and Frey, P. A.
(1989)
Biochemistry
28,
2645-2654
44.
Thoden, J. B.,
Frey, P. A.,
and Holden, H. M.
(1996)
Biochemistry
35,
5137-5144
45.
Thoden, J. B.,
Frey, P. A.,
and Holden, H. M.
(1996)
Biochemistry
35,
2557-2566
46.
Johnson, A. E.,
and Tanner, M. E.
(1998)
Biochemistry
37,
5746-5754
47.
Morgan, P. M.,
Sla, R. F.,
and Tanner, M. E.
(1997)
J. Am. Chem. Soc.
119,
10269-10277
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
E. L. Westman, A. Preston, R. A. Field, and J. S. Lam Biosynthesis of a Rare Di-N-Acetylated Sugar in the Lipopolysaccharides of both Pseudomonas aeruginosa and Bordetella pertussis Occurs via an Identical Scheme despite Different Gene Clusters J. Bacteriol., September 15, 2008; 190(18): 6060 - 6069. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Valiente, N. Jimenez, S. Merino, J. M. Tomas, and C. Amaro Vibrio vulnificus Biotype 2 Serovar E gne but Not galE Is Essential for Lipopolysaccharide Biosynthesis and Virulence Infect. Immun., April 1, 2008; 76(4): 1628 - 1638. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Miller, M. J. Matewish, D. J. McNally, N. Ishiyama, E. M. Anderson, D. Brewer, J.-R. Brisson, A. M. Berghuis, and J. S. Lam Flagellin Glycosylation in Pseudomonas aeruginosa PAK Requires the O-antigen Biosynthesis Enzyme WbpO J. Biol. Chem., February 8, 2008; 283(6): 3507 - 3518. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Cunneen and P. R. Reeves The Yersinia kristensenii O11 O-Antigen Gene Cluster was Acquired by Lateral Gene Transfer and Incorporated at a Novel Chromosomal Locus Mol. Biol. Evol., June 1, 2007; 24(6): 1355 - 1365. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Canals, N. Jimenez, S. Vilches, M. Regue, S. Merino, and J. M. Tomas Role of Gne and GalE in the Virulence of Aeromonas hydrophila Serotype O34 J. Bacteriol., January 15, 2007; 189(2): 540 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vijayakumar, A. Merkx-Jacques, D. B. Ratnayake, I. Gryski, R. K. Obhi, S. Houle, C. M. Dozois, and C. Creuzenet Cj1121c, a Novel UDP-4-keto-6-deoxy-GlcNAc C-4 Aminotransferase Essential for Protein Glycosylation and Virulence in Campylobacter jejuni J. Biol. Chem., September 22, 2006; 281(38): 27733 - 27743. [Abstract] [Full Text] [PDF] |
||||